<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	>
<channel>
	<title>Comments on: Dear FDA: $50K Is Still A Lot Of Money</title>
	<atom:link href="http://www.pharmalot.com/2007/03/dear_fda_50k_is_still_a_lot_of/feed" rel="self" type="application/rss+xml" />
	<link>http://www.pharmalot.com/2007/03/dear_fda_50k_is_still_a_lot_of/</link>
	<description>News, Comment and Conversation</description>
	<pubDate>Sat, 20 Mar 2010 06:28:45 +0000</pubDate>
	<generator>http://wordpress.org/?v=2.6.2</generator>
		<item>
		<title>By: pjcruz</title>
		<link>http://www.pharmalot.com/2007/03/dear_fda_50k_is_still_a_lot_of/#comment-2950</link>
		<dc:creator>pjcruz</dc:creator>
		<pubDate>Mon, 26 Mar 2007 20:40:10 +0000</pubDate>
		<guid isPermaLink="false">http://plt.starledger.webfactional.com/2007/03/dear_fda_50k_is_still_a_lot_of/#comment-2950</guid>
		<description>As one who has received gifts or dollars from drug manufactures for "listening to information about their product" in the past, I think $50,000 is too high.  The mark should be more like $500 to $1000 dollars annually per manufacturer up to a total of $5000.  Only when the figure becomes insignificant to the receiver, will a true assessment of the drug product be done.  
</description>
		<content:encoded><![CDATA[<p>As one who has received gifts or dollars from drug manufactures for &#8220;listening to information about their product&#8221; in the past, I think $50,000 is too high.  The mark should be more like $500 to $1000 dollars annually per manufacturer up to a total of $5000.  Only when the figure becomes insignificant to the receiver, will a true assessment of the drug product be done.</p>
]]></content:encoded>
	</item>
</channel>
</rss>
